BSMC - ETF AI Analysis
Top Page
Brandes U.S. Small-Mid Cap Value ETF (BSMC)
Rating:66Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown strong gains so far this year and in the last month, indicating positive recent momentum.
Solid Top Holdings
Several of the largest positions, including Innovex International, Ingles Markets, UniFirst, Kennametal, and IPG Photonics, have delivered strong year-to-date results that support the fund’s overall performance.
Diversified Sector Mix
Holdings spread across health care, industrials, technology, consumer sectors, financials, energy, and more help reduce the impact if any one industry struggles.
Negative Factors
Relatively High Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which can eat into long-term returns compared with lower-cost options.
Heavy U.S. Concentration
With the vast majority of assets in U.S. stocks and only small exposure to the UK and Canada, the fund offers limited geographic diversification.
Some Weak Top Holdings
A few key positions, such as Amdocs and Elanco Animal Health, have shown weak or negative performance this year, which can drag on the fund if those stocks do not recover.
BSMC vs. SPDR S&P 500 ETF (SPY)
AUM163.09M
RegionNorth America
Expense Ratio0.71%
Beta0.74
IssuerBrandes
Inception DateOct 03, 2023
Dividend Yield0.95%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume8,873
30 Day Avg. Volume18,517
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
43.40Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering69
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BSMC Summary
The Brandes U.S. Small-Mid Cap Value ETF (BSMC) focuses on smaller and mid-sized U.S. companies that the managers believe are undervalued. It doesn’t track a set index, but instead selects a mix of businesses across health care, industrials, technology, and other sectors. Well-known names in the fund include International Flavors & Fragrances and Elanco Animal Health. Investors might consider BSMC if they want diversification beyond large, famous companies and see potential growth in overlooked stocks. A key risk is that smaller company shares can be more volatile and can go up or down more sharply than the overall market.
How much will it cost me?The Brandes U.S. Small-Mid Cap Value ETF (BSMC) has an expense ratio of 0.7%, which means you’ll pay $7 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on selecting undervalued small and mid-sized companies through detailed analysis.
What would affect this ETF?BSMC could benefit from a strong U.S. economy, as small and mid-sized companies often thrive during periods of growth, and its focus on undervalued stocks may provide opportunities if market sentiment shifts toward value investing. However, rising interest rates or economic slowdowns could negatively impact smaller companies, and sector-specific challenges in areas like Health Care or Technology, which have significant weight in the ETF, may also pose risks.
BSMC Top 10 Holdings
BSMC leans heavily into U.S. small and mid-cap value names, with a clear tilt toward health care and industrials. Recent strength from IPG Photonics, Kennametal, and UniFirst has been doing the heavy lifting, giving the fund a lift as these “quiet workhorses” keep rising. Innovex and Ingles Markets are also pulling their weight with steady gains. On the flip side, Elanco Animal Health and DENTSPLY SIRONA have been lagging, acting as a bit of a brake. Overall, it’s a domestically focused, sector-diversified value play with a few standout winners.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Innovex International | 2.88% | $4.69M | $1.83B | 79.12% | 76 Outperform | |
| International Flavors & Fragrances | 2.83% | $4.60M | $20.69B | 10.38% | 61 Neutral | |
| Ingles Markets | 2.82% | $4.59M | $1.61B | 40.84% | 72 Outperform | |
| Elanco Animal Health | 2.62% | $4.27M | $11.81B | 97.74% | 69 Neutral | |
| DENTSPLY SIRONA | 2.51% | $4.09M | $2.20B | -30.42% | 46 Neutral | |
| Amdocs | 2.45% | $3.98M | $6.86B | -30.31% | 69 Neutral | |
| UniFirst | 2.32% | $3.78M | $4.39B | 37.14% | 72 Outperform | |
| Netgear | 2.30% | $3.74M | $737.29M | -5.83% | 49 Neutral | |
| Pediatrix Medical Group | 2.22% | $3.62M | $1.93B | 61.80% | 76 Outperform | |
| Kennametal | 2.19% | $3.57M | $2.75B | 73.56% | 72 Outperform |
BSMC Technical Analysis
Positive
―
Price Trends
37.13
Positive
36.80
Positive
34.90
Positive
Market Momentum
0.31
Positive
54.54
Neutral
64.89
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BSMC, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 38.06, equal to the 50-day MA of 37.13, and equal to the 200-day MA of 34.90, indicating a bullish trend. The MACD of 0.31 indicates Positive momentum. The RSI at 54.54 is Neutral, neither overbought nor oversold. The STOCH value of 64.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BSMC.
BSMC Peer Comparison
Comparison Results
Performance Comparison
BSMC
Brandes U.S. Small-Mid Cap Value ETF
38.09
7.56
24.76%
RSMC
Rockefeller U.S. Small-Mid Cap ETF
―
―
―
MSSM
Morgan Stanley Pathway Small-Mid Cap Equity ETF
―
―
―
GRNJ
Fundstrat Granny Shots US Small- & Mid-Cap ETF
―
―
―
CSMD
Congress SMid Growth ETF
―
―
―
SMIZ
Zacks Small/Mid Cap ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents